US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 1.680
  • +0.020+1.20%
Close Dec 20 16:00 ET
  • 1.680
  • +0.000+0.01%
Post 19:28 ET
191.34MMarket Cap-1.02P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fate Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 1.197M --
-- 2024/Q4 -- / 1.567M --
-- 2024/Q3 3.074M / 1.445M --
-- 2024/Q2 6.772M / 1.548M --
May 9, 2024 2024/Q1 1.925M / 1.260M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.197M--
--2024/Q4-- / 1.567M--
--2024/Q33.074M / 1.445M--
--2024/Q26.772M / 1.548M--
May 9, 20242024/Q11.925M / 1.260M--

Unlock Free Earnings Estimates

Fate Therapeutics Earnings Reports

  • Fate Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 05:11

  • Fate Therapeutics | 8-K: Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

    Nov 13 05:10

  • Fate Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:14

  • Fate Therapeutics | 8-K: Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates

    Aug 14 04:08

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data